Becton Dickinson & Co. stock outperforms competitors on strong trading day
Becton Dickinson & Co. closed 3.20% below its 52-week high of $248.42, which the company achieved on March 28th.
Becton, Dickinson and Company's SWOT analysis: med tech stock poised for growth
Becton, Dickinson and Company (NYSE:BDX), a leading player in the medical technology sector with a market capitalization of ...
Hosted on MSN1d
BD Stock Rises on Biosero Deal for AI-Powered Robotic Cytometry Tech
Becton, Dickinson and Company BDX, popularly known as BD, recently announced a collaboration with Biosero, a developer of ...
Becton Dickinson, Biosero announce framework collaboration agreement
Becton, Dickinson and Company and Biosero, a developer of laboratory automation solutions to orchestrate scientific discoveries, announced a ...
Assembly Mag3d
Becton Dickinson Boosts U.S. Manufacturing of Critical Medical Devices
Becton, Dickinson and Co. (BD) is investing in its U.S. manufacturing network to add capacity for critical medical devices, ...
Leadership Success Story Of Abhijeet Bhardwaj's Revenue Re-Architecture Project At Becton Dickinson
Abhijeet Bhardwaj's commitment to technical excellence and innovation continues to drive successful outcomes in large-scale ...
bovnews4d
Why Is Becton Dickinson and Co (BDX) Stock Surpassing 4.30% from Its 50-Day SMA?
Becton Dickinson and Co (BDX) stock saw a modest uptick, ending the day at $237.38 which represents a slight increase of $1.08 or 0.46% from the prior close of $236.3. The stock opened at $236.51 and ...
Jefferson nurses reported a defective IV needle and contributed to a national recall. Jefferson wants more staffers to report potential problems.
Paoletti, a charge nurse at Jefferson Torresdale Hospital, reported the problem internally, through the health system’s Great ...
Gateway Investment Advisers LLC Has $379,000 Stake in Becton, Dickinson and Company (NYSE:BDX)
Gateway Investment Advisers LLC reduced its position in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) by ...
TMCnet2d
BD and Biosero Collaborate to Enable Robotic Integration with Flow Cytometers Used in Drug Discovery and Development
The new versions of BD flow cytometer instrument software compatible with Biosero automation software for the BD FACSymphony A1™ Cell Analyzer, BD FACSymphony™ A5 SE Cell Anal ...
Becton Dickinson & Co. stock underperforms Wednesday when compared to competitors
Shares of Becton Dickinson & Co. BDX shed 1.02% to $237.92 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.61% to 6,086 ...
BD And Biosero Partner To Integrate Robotics With Flow Cytometry
BD. (BDX), a global medical technology company, and Biosero, a developer of laboratory automation solutions, Thursday announced that ...